BenevolentAI
About Company
“Empowering drug discovery with AI innovation.”
BenevolentAI is a company that uses AI to empower scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering successful drugs. The company has a rich drug pipeline that mixes both potentially best-in-class and first-in-class drug candidates, all entirely generated using the Benevolent Platform™. They also partner with leading pharmaceutical and biotech companies to tackle therapeutic challenges from new angles and develop novel drugs for complex multifactorial diseases. BenevolentAI’s AI-enabled drug discovery engine is designed to drive a revolution in drug discovery by unlocking the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. The company is also actively involved in collaborations with AstraZeneca and Merck, and it is progressing five of its most advanced high-potential clinical and preclinical assets to their next inflection points. Additionally, BenevolentAI offers career opportunities for individuals to work on a mission that matters, uniting AI and cutting-edge science to discover and develop new medicines for complex diseases.
